Es-Is Technologies

Company Overview

Snapshot

Founded in January 2010 by Ehud Wizer, Es-Is Technologies operates with 1–10 employees. The company focuses on developing enzyme-catalyzed processes for drug synthesis, a core activity within the Health Tech & Life Sciences sector. In March 2015, a company founder shared insights at a biotechnology meetup, highlighting the company's engagement within the biotech community.

Business overview

Es-Is Technologies leverages computational power to develop enzyme-catalyzed processes for the rapid and cost-effective synthesis of pharmaceutical ingredients. The company designs novel, enzyme-based syntheses for creating synthetic chemicals using advanced computer algorithms and an understanding of biomolecules at an atomic level. Es-Is collaborates with pharmaceutical companies to integrate clean chemo-enzymatic processes, aiming to replace purely chemical drug production methods that consume excess resources and contribute to pollution. The company operates within the Health Tech & Life Sciences sector, specifically targeting the pharmaceutical industry with its B2B business model.

Company Intelligence Q&A

When was Es-Is Technologies founded?

Es-Is Technologies was founded in January 2010.

Who is the co-founder and CEO of Es-Is Technologies?

Ehud Wizer is the Co-Founder and CEO of Es-Is Technologies.

What is the primary focus of Es-Is Technologies?

Es-Is Technologies focuses on developing novel, enzyme-based syntheses for the production of pharmaceutical ingredients, utilizing computing power to create enzyme-catalyzed processes.

What is EnzyMatrix?

EnzyMatrix is a product developed by Es-Is Technologies, designed to facilitate the introduction of clean chemo-enzymatic processes in drug production.

Which markets does Es-Is Technologies serve?

Es-Is Technologies serves geomarkets including India, Spain, Europe, and China.